Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,185 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Case-control study of phyto-oestrogens and breast cancer.
Ingram D, Sanders K, Kolybaba M, Lopez D. Ingram D, et al. Lancet. 1997 Oct 4;350(9083):990-4. doi: 10.1016/S0140-6736(97)01339-1. Lancet. 1997. PMID: 9329514
Five-year survival from breast cancer in Western Australia over a decade.
Clayforth C, Fritschi L, McEvoy SP, Byrne MJ, Ingram D, Sterrett G, Harvey JM, Joseph D, Jamrozik K. Clayforth C, et al. Among authors: ingram d. Breast. 2007 Aug;16(4):375-81. doi: 10.1016/j.breast.2007.01.010. Epub 2007 Apr 19. Breast. 2007. PMID: 17448661
Life events and the risk of breast cancer: a case-control study.
Ginsberg A, Price S, Ingram D, Nottage E. Ginsberg A, et al. Among authors: ingram d. Eur J Cancer. 1996 Nov;32A(12):2049-52. doi: 10.1016/s0959-8049(96)00275-4. Eur J Cancer. 1996. PMID: 9014743
The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer. The South Australian Breast Cancer Study Group.
Seshadri R, Horsfall DJ, Firgaira F, McCaul K, Setlur V, Chalmers AH, Yeo R, Ingram D, Dawkins H, Hahnel R. Seshadri R, et al. Among authors: ingram d. Int J Cancer. 1994 Jan 2;56(1):61-5. doi: 10.1002/ijc.2910560112. Int J Cancer. 1994. PMID: 8262679
Total tumor cathepsin D (TCD) levels were determined prospectively by a radioimmunometric assay in tumor cytosol of 858 primary breast cancer patients diagnosed between 1989-1991. ...
Total tumor cathepsin D (TCD) levels were determined prospectively by a radioimmunometric assay in tumor cytosol of 858 primary breas …
Diet and subsequent survival in women with breast cancer.
Ingram D. Ingram D. Br J Cancer. 1994 Mar;69(3):592-5. doi: 10.1038/bjc.1994.108. Br J Cancer. 1994. PMID: 8123493 Free PMC article.
The effect of hormone replacement therapy on prognostic indices in women with breast cancer.
Jones C, Ingram D, Mattes E, Hahnel R. Jones C, et al. Among authors: ingram d. Med J Aust. 1994 Jul 18;161(2):106-10. Med J Aust. 1994. PMID: 8028534
MAIN OUTCOME MEASURES: Biochemical indices of oestrogen receptor, progesterone receptor, cathepsin D and protein levels, and pathological indices of tumour size, tumour differentiation and lymph node involvement for users and nonusers of HRT. ...The mean cathepsin D
MAIN OUTCOME MEASURES: Biochemical indices of oestrogen receptor, progesterone receptor, cathepsin D and protein levels, and patholog …
Obesity and breast disease. The role of the female sex hormones.
Ingram D, Nottage E, Ng S, Sparrow L, Roberts A, Willcox D. Ingram D, et al. Cancer. 1989 Sep 1;64(5):1049-53. doi: 10.1002/1097-0142(19890901)64:5<1049::aid-cncr2820640515>3.0.co;2-m. Cancer. 1989. PMID: 2758382
Preventing breast cancer: is it possible?
Ingram D. Ingram D. Aust N Z J Surg. 1991 Dec;61(12):884-91. doi: 10.1111/j.1445-2197.1991.tb00004.x. Aust N Z J Surg. 1991. PMID: 1755767
Estradiol binding to plasma proteins after changing to a low-fat diet.
Ingram D, Bennett F, Wood A. Ingram D, et al. Nutr Cancer. 1989;12(4):327-32. doi: 10.1080/01635588909514033. Nutr Cancer. 1989. PMID: 2608537 Clinical Trial.
Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene.
Beilby J, Ingram D, Hähnel R, Rossi E. Beilby J, et al. Among authors: ingram d. Eur J Cancer. 2004 May;40(8):1250-4. doi: 10.1016/j.ejca.2004.01.026. Eur J Cancer. 2004. PMID: 15110890
1,185 results
Jump to page
Feedback